scispace - formally typeset
T

Tsukasa Osaki

Researcher at Yamagata University

Publications -  41
Citations -  623

Tsukasa Osaki is an academic researcher from Yamagata University. The author has contributed to research in topics: Autoantibody & Factor XIII. The author has an hindex of 13, co-authored 41 publications receiving 480 citations.

Papers
More filters
Journal ArticleDOI

Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.

TL;DR: As horseshoe crab is a close relative of the spider, tachystatins and spider neurotoxins may have evolved from a common ancestral peptide, with adaptive functions.
Journal ArticleDOI

Large-scale Identification of Endogenous Secretory Peptides Using Electron Transfer Dissociation Mass Spectrometry

TL;DR: ETD was used, in comparison to collision induced dissociation (CID), to identify endogenous peptides derived from secretory granules of a human endocrine cell line and this advantage was demonstrated in identifying a new antimicrobial peptide from neurosecretory protein VGF, VGF[554–577]-NH2, or in differentiating nearly isobaric peptides that arise from alternatively spliced exons of the gastrin-releasing peptide gene.
Journal ArticleDOI

The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking

TL;DR: It is demonstrated that FXIII-B accelerates fibrin cross-linking and plays important roles in the formation of a ternary complex between proenzyme FXIII, prosubstrate fibr inogen, and activator thrombin.
Journal ArticleDOI

Peptidomics-based discovery of an antimicrobial peptide derived from insulin-like growth factor-binding protein 5.

TL;DR: This study exemplifies the impact of peptidomics to study naturally occurring peptides and identifies a novel intramolecular disulfide-linked 22-residue amidated peptide, designated AMP-IBP5, which showed antimicrobial activity against six of the eight microorganisms tested at concentrations comparable to or lower than those for well-characterized AMPs cathelicidin and β-defensin-2.